RecruitingNot ApplicableNCT06497283
Binaural Sound for Remimazolam Maintenance
The Effect of Intraoperative Binaural Sound on Remifentanil Dose Required for General Anesthesia Using Remimazolam: a Randomized, Placebo-controlled Trial
Sponsor
Gangnam Severance Hospital
Enrollment
72 participants
Start Date
Jul 12, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remimazolam infusion.
Eligibility
Min Age: 20 Years
Inclusion Criteria4
- Patients scheduled for general anesthesia
- Patients aged 20-60
- Patients with American Society of Anesthesiologist physical status classification 1-2
- Patients with ideal body weight 50-80 kg
Exclusion Criteria6
- Patients with hearing disability
- Patients using opioids or sedatives in 1 week
- Patients who are dependent for alcoholics or drugs
- Patients with hypersensitivities to remimazolam or remifentanil
- Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
- Patients with liver failure
Interventions
PROCEDUREBinaural sound
Binaural sound: Binaural sound will be applied.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06497283
Related Trials
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
NCT072032871 location
Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor
NCT071652361 location
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
NCT064193481 location
Lidocaine, Dexmedetomidine, Esmolol and Magnesium Effect on Optic Nerve Sheath Diameter After Laryngoscopy
NCT062545341 location
Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
NCT066581451 location